In what looks like a natural cleaving of its sizeable business, Baxter International says it plans to create two independent global healthcare companies, effectively separating its biopharmaceuticals and medical products.
Baxter
CE Mark Brings Baxter’s VIVIA High Dose Hemodialysis System to Europe
Baxter International Inc. has gained CE mark approval for its VIVIA hemodialysis (HD) system, designed to deliver more frequent, extended duration, short daily or nocturnal home HD therapy, known as High Dose HD therapy.
Baxter Confirms Gambro Acquisition
Baxter International Inc. will acquire Swedish dialysis products company Gambro AB for a total consideration of a mere 26.5 billion SEK (approximately “a mere” $4.0 billion USD)
Device Alert: Baxter Sterile Water For Irrigation
One specific LOT of Baxter’s sterile water for irrigation may be contaminated by a bacterium. As a precautionary measure the company is acting and UK’s regulatory body has issued a device alert calling for quarantining of identified product as further investigation is performed.
Baxter International Quarterly Financials On Target
Baxter International Inc. has announced financial results for the second quarter and confirmed its full-year 2012 financial outlook. Sales increase of 4% year-on-year coupled with 1% income hike is in line with previous guidance.
Medical Device Alert: Pump/gravity Blood Administration Set Used In Conjunction With Baxter Flogard And Colleague Infusion Pumps
UK competent authority the MHRA has issued a Medical Device Alert pertaining to Baxter’s Flogard and Colleague infusion pumps, one lot of which may have been incorrectly assembled.
Baxter Completes Acquisition Of Synovis
Baxter’s previously advertised agreement to buy Synovis has now been consummated with the approval of Synovis’ shareholders.
New International Boss For Baxter
Baxter International Inc. has announced that Jean-Luc Butel has been appointed corporate vice president and president, international and will assume his new role on February 20, 2012.
Baxter To Acquire Synovis
Baxter International Inc. and Synovis Life Technologies, Inc. have announced a definitive agreement for Baxter to acquire Synovis, a leading provider of biological and mechanical products for soft tissue repair used in a variety of surgical procedures.
Dialysis At Home: Baxter To Fund Two Research Studies
Baxter Healthcare is providing over £200,000 of funding to two UK studies with the goal of establishing an improved evidence base for home dialysis treatment.
Medical Device Alert on Aquarius Haemofiltration Device
UK MHRA has issued a Medical Device Alert (MDA) on the Aquarius Haemofiltration Device manufactured by Nikkiso Europe GmBH and distributed by Baxter Healthcare.
Baxter Announces FDA Approval of ARTISS Fibrin Sealant For Use in Face-Lift (Facial Rhytidectomy) Procedures
Baxter International Inc. has announced that FDA has expanded the indication of ARTISS [Fibrin Sealant (Human)] to include adhering tissue flaps during facial rhytidectomy surgery (face-lift)
Growth of Chronic Kidney Disease Highlights Need for Early Detection
An increasing numbers of patients progressing to kidney disease and kidney failure place a financial strain on public health systems.
FDA Classifies Recent Urgent Device Correction on Baxter’s Colleague Infusion Pump as a Class I Recall
Baxter International Inc. announced today that the U.S. Food and Drug Administration has classified Baxter’s January 23, 2009 Urgent Device Correction letter to customers regarding U.S. COLLEAGUE® Volumetric Infusion Pumps as a Class I recall.
Baxter Declares Quarterly Dividend
The Board of Directors of Baxter International Inc. today declared a quarterly dividend of $0.26 per share of Baxter common stock.
Baxter gets CE Marking for Coseal
Baxter’s COSEAL Surgical Sealant gets CE marked and launched.